These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6732812)

  • 1. Effects of verapamil on the binding properties of rat heart muscarinic receptors: evidence for an allosteric site.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    Biochem Biophys Res Commun; 1984 May; 121(1):340-5. PubMed ID: 6732812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of quinidine on rat heart muscarinic receptors.
    Waelbroeck M; De Neef P; Robberecht P; Christophe J
    Life Sci; 1984 Sep; 35(10):1069-76. PubMed ID: 6482646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
    Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
    Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
    Maass A; Mohr K
    Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition between positive and negative allosteric effectors on muscarinic receptors.
    Proska J; Tucek S
    Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
    Tränkle C; Mohr K
    Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil on the binding characteristics of muscarinic receptor subtypes.
    Baumgold J
    Eur J Pharmacol; 1986 Jul; 126(1-2):151-4. PubMed ID: 3758159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple effects of short-chain alcohols on binding to rat heart muscarinic receptors.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    Biochem J; 1984 Apr; 219(2):563-71. PubMed ID: 6743233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.
    Waelbroeck M
    Mol Pharmacol; 1994 Oct; 46(4):685-92. PubMed ID: 7969047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD; Vaishnav AA; Mash DC
    Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
    Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
    Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors.
    Hou X; Wehrle J; Menge W; Ciccarelli E; Wess J; Mutschler E; Lambrecht G; Timmerman H; Waelbroeck M
    Br J Pharmacol; 1996 Mar; 117(5):955-61. PubMed ID: 8851517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ; Delen FM
    Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
    Musílková J; Tucek S
    Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.